SRDX Stock Price Chart More Charts

SRDX Price/Volume Stats

Surmodics, Inc. (SRDX) Company Bio

SurModics Inc. provides surface modification and in vitro diagnostic technologies to the healthcare industry. The company operates through two segments, Medical Device and In Vitro Diagnostics. The company was founded in 1979 and is based in Eden Prairie, Minnesota.

SRDX Price Forecast Based on DCF Valuation

We started the process of determining a valid price forecast for Surmodics Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Surmodics Inc ranked in the 8st percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 95%. As for the metrics that stood out in our discounted cash flow analysis of Surmodics Inc, consider:

• Its compound free cash flow growth rate, as measured over the past 5.76 years, is -0.13% -- higher than only 13.77% of stocks in our DCF forecasting set.
• As a business, SRDX is generating more cash flow than merely 19.32% of positive cash flow stocks in the Healthcare.
• The business' balance sheet suggests that 0% of the company's capital is sourced from debt; this is greater than only 0% of the free cash flow producing stocks we're observing.

CRY, ELAN, GRFS, PHG, and MEDS can be thought of as valuation peers to SRDX, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.